Table 3.
Parameter | Adenine Administration Period | |||
---|---|---|---|---|
0 wk | 2 wk | 4 wk | 5 wk | |
Urinary volume (ml/6 h) | ||||
Group LPa | 5.83±1.79 | 2.37±1.44 | 1.95±1.20 | 2.31±2.12 |
Group Adeb | 5.59±2.49 | 7.65±3.16 | 6.71±2.28 | 4.50±4.80 |
Group Gly | 3.27±1.53 | 5.99±1.90 | 5.04±2.21 | 3.37±2.82 |
Group Lys | 4.09±1.99 | 5.85±2.68 | 6.42±2.59 | 3.01±2.95 |
Calcium/creatinine | ||||
Group LP | 0.141±0.090 | 0.041±0.021 | 0.098±0.067 | 0.085±0.033 |
Group Adeb | 0.146±0.070 | 0.018±0.012 | 0.123±0.073 | 0.224±0.037 |
Group Gly | 0.164±0.060 | 0.012±0.011 | 0.138±0.055 | 0.306±0.111 |
Group Lysc | 0.176±0.078 | 0.064±0.043 | 0.274±0.084 | 0.490±0.155 |
Magnesium/creatinine | ||||
Group LP | 0.534±0.251 | 0.123±0.042 | 0.130±0.064 | 0.212±0.125 |
Group Adeb | 0.533±0.225 | 0.396±0.099 | 0.351±0.108 | 0.453±0.135 |
Group Gly | 0.448±0.115 | 0.260±0.065 | 0.399±0.093 | 0.203±0.170 |
Group Lys | 0.369±0.172 | 0.282±0.082 | 0.363±0.060 | 0.152±0.137 |
Phosphate/creatinine | ||||
Group LPa | 0.098±0.072 | 2.044±1.112 | 2.503±0.686 | 2.338±1.076 |
Group Adeb | 0.399±0.486 | 2.117±0.340 | 2.930±0.526 | 4.474±0.868 |
Group Gly | 0.405±0.403 | 1.889±0.459 | 2.760±0.306 | 4.450±0.958 |
Group Lys | 0.334±0.383 | 2.185±0.415 | 2.775±0.531 | 4.142±0.548 |
Urinary parameters are summarized. All results are presented as means±SD. Statistical significance was evaluated by multivariate ANOVA (n=4–7 in each group).
P<0.05.
Reference group.
P<0.01.